Evidence map›Paper›PMID 33762657›Full record

ArticleScientific reports2021

Identifying the major lactate transporter of Toxoplasma gondii tachyzoites.

Joy M Zeng, Sanduni V Hapuarachchi, Sarah H Shafik, Rowena E Martin, Kiaran Kirk, Giel G van Dooren, Adele M Lehane

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. A two-membrane gateway for monocarboxylates couples host glycolysis tobioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Microbial membrane transport proteins and their biotechnological applications.World journal of microbiology & biotechnology · 2024
    Review
  9. Metabolic changes to host cells withbioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joy M ZengResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia.
Sanduni V HapuarachchiResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia.
Sarah H ShafikResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia.
Rowena E MartinResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia.
Kiaran KirkResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia.
Giel G van DoorenResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia. giel.vandooren@anu.edu.au.
Adele M LehaneResearch School of Biology, Australian National University, Canberra, ACT, 2601, Australia. adele.lehane@anu.edu.au.
Australian National University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasma gondii and Plasmodium falciparum parasites both extrude L-lactate, a byproduct of glycolysis. The P. falciparum Formate Nitrite Transporter, PfFNT, mediates L-lactate transport across the plasma membrane of P. falciparum parasites and has been validated as a drug target. The T. gondii genome encodes three FNTs that have been shown to transport L-lactate, and which are proposed to be the targets of several inhibitors of T. gondii proliferation. Here, we show that each of the TgFNTs localize to the T. gondii plasma membrane and are capable of transporting L-lactate across it, with TgFNT1 making the primary contribution to L-lactate transport during the disease-causing lytic cycle of the parasite. We use the Xenopus oocyte expression system to provide direct measurements of L-lactate transport via TgFNT1. We undertake a genetic analysis of the importance of the tgfnt genes for parasite proliferation, and demonstrate that all three tgfnt genes can be disrupted individually and together without affecting the lytic cycle under in vitro culture conditions. Together, our experiments identify the major lactate transporter in the disease causing stage of T. gondii, and reveal that this transporter is not required for parasite proliferation, indicating that TgFNTs are unlikely to be targets for anti-Toxoplasma drugs.

Indexed as

AnimalsCell MembraneLactic AcidMonocarboxylic Acid TransportersOocytesProtein IsoformsProtozoan ProteinsToxoplasmaXenopusLactic AcidMonocarboxylic Acid TransportersProtein IsoformsProtozoan Proteins

Identifiers

PMID33762657
PMCPMC7991638
OpenAlexW3138573423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.